Guy Kubi Elevated to Chief Operating Officer at Alcami Corporation Amid Growth Plans

Alcami Corporation Appoints Guy Kubi as COO

Alcami Corporation, a prominent U.S.-based contract development and manufacturing organization (CDMO), has recently announced the elevation of Guy Kubi to the role of Chief Operating Officer (COO). This significant transition is taking place at a time when Alcami is focused on expansion and growth. Kubi's extensive experience within the company and the industry at large positions him as an ideal candidate to spearhead the next phase of Alcami's operations.

Guy Kubi, who previously held the title of Chief Business Officer, will now take on broader responsibilities overseeing key departments including Human Resources, Quality, Commercial, Project Management, Corporate Development, and Pharma Storage and Services Operations. His direct reporting line will be to Patrick Walsh, the Chairman and CEO of Alcami, who expressed confidence in Kubi’s leadership capabilities. Walsh noted, "Guy has been instrumental in cultivating a high-growth and client-centric culture while delivering business success. His proven tenacity and leadership will serve Alcami well in the next phase of growth and expansion."

With over a decade of service at Alcami, Kubi has demonstrated exceptional leadership skills. He embarked on his career in the finance department after graduating with a BS in Finance from Winthrop University, where he also excelled as a Division I tennis scholar-athlete. Following his tenure at Alcami, Kubi gained further experience at Avista Pharma Solutions in various roles of increasing responsibility. He also holds an inactive CPA license in North Carolina.

In a statement reflecting on his new position, Kubi shared his enthusiasm: "It is extremely exciting to be a leader at Alcami through such a monumental period of growth. We built great momentum in 2025, adding double-digit growth to both top and bottom lines. The growth will further accelerate in 2026 as Alcami continues to be a strong and preferred partner in the industry."

Alcami Corporation has been at the forefront of pharmaceutical and biologic development for over 45 years, offering fully integrated laboratory services, drug product manufacturing, and cGMP storage solutions. With a dedication to advancing pharmaceuticals from development to delivery, Alcami's commitment to quality and innovation is evident. The firm is backed by private equity investors, including GHO Capital, The Vistria Group, and Ampersand Capital Partners.

The appointment of Guy Kubi as COO comes at an exciting juncture for Alcami, one that is characterized by an ambitious vision for future growth and an unwavering commitment to providing exceptional services in the pharmaceutical sector. As Alcami continues to enhance its operations and strengthen its position in the market, Kubi's leadership will be pivotal in navigating the evolving landscape of healthcare and manufacturing.

For more information about Alcami Corporation and its services, please visit www.alcami.com.